Endometrial Cancer: Transitioning from Histology to Genomics

por Mitric, Cristina, Bernardini, Marcus Q.
Publicado 2022

Clear Cell Carcinoma of the Endometrium Causing Paraneoplastic Retinopathy: Case Report and Review of the Literature

por Cybulska, Paulina, Navajas, Eduardo V., Altomare, Filiberto, Bernardini, Marcus Q.
Publicado 2011

High-throughput approaches for precision medicine in high-grade serous ovarian cancer

por Govindarajan, Meinusha, Wohlmuth, Christoph, Waas, Matthew, Bernardini, Marcus Q., Kislinger, Thomas
Publicado 2020

The role of KIF14 in patient-derived primary cultures of high-grade serous ovarian cancer cells

por Thériault, Brigitte L, Cybulska, Paulina, Shaw, Patricia A, Gallie, Brenda L, Bernardini, Marcus Q
Publicado 2014

Use of Porphysomes to detect primary tumour, lymph node metastases, intra-abdominal metastases and as a tool for image-guided lymphadenectomy: proof of concept in endometrial cance...

por Philp, Lauren, Chan, Harley, Rouzbahman, Marjan, Overchuk, Marta, Chen, Juan, Zheng, Gang, Bernardini, Marcus Q.
Publicado 2019

Risk reduction strategies for BRCA1/2 hereditary ovarian cancer syndromes: a clinical practice guideline

por Jacobson, Michelle, Coakley, Nadia, Bernardini, Marcus, Branco, Kelly-Ann, Elit, Laurie, Ferguson, Sarah, Kim, Raymond
Publicado 2021

Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden

por Ren, Annie, Prassas, Ioannis, Sugumar, Vijithan, Soosaipillai, Antoninus, Bernardini, Marcus, Diamandis, Eleftherios P, Kulasingam, Vathany
Publicado 2021

Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics

por Leung, Felix, Bernardini, Marcus Q., Liang, Kun, Batruch, Ihor, Rouzbahman, Marjan, Diamandis, Eleftherios P., Kulasingam, Vathany
Publicado 2018

(18)F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study

por Metser, Ur, Kulanthaivelu, Roshini, Chawla, Tanya, Johnson, Sarah, Avery, Lisa, Hussey, Douglas, Veit-Haibach, Patrick, Bernardini, Marcus, Hogen, Liat
Publicado 2022

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program

por Care, Melanie, McCuaig, Jeanna, Clarke, Blaise, Grenier, Sylvie, Kim, Raymond H, Rouzbahman, Marjan, Stickle, Natalie, Bernardini, Marcus, Stockley, Tracy L.
Publicado 2020

Gynecologic oncology and surgical oncology treatment modifications, cancellations or delays in response to the COVID-19 pandemic in public versus private cancer centers in North Am...

por Piedimonte, Sabrina, Li, Sue, Laframboise, Stephane, Ferguson, Sarah, Bernardini, Marcus, Bouchard-Fortier, Genevieve, Hogen, Liat, Cybulska, Paulina, Worley, Michael, May, Taymaa
Publicado 2021

Deciphering the peptidome of urine from ovarian cancer patients and healthy controls

por Smith, Christopher R, Batruch, Ihor, Bauça, Josep Miquel, Kosanam, Hari, Ridley, Julia, Bernardini, Marcus Q, Leung, Felix, Diamandis, Eleftherios P, Kulasingam, Vathany
Publicado 2014

A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers

por Tinker, Anna V., Altman, Alon D., Bernardini, Marcus Q., Ghatage, Prafull, Gien, Lilian T., Provencher, Diane, Salvador, Shannon, Doucette, Sarah, Oza, Amit M.
Publicado 2022

Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites

por Feigenberg, Tomer, Clarke, Blaise, Virtanen, Carl, Plotkin, Anna, Letarte, Michelle, Rosen, Barry, Bernardini, Marcus Q., Kollara, Alexandra, Brown, Theodore J., Murphy, K. Joan
Publicado 2014

Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center

por Piedimonte, Sabrina, Li, Sue, Laframboise, Stephane, Ferguson, Sarah E., Bernardini, Marcus Q., Bouchard-Fortier, Genevieve, Hogen, Liat, Cybulska, Paulina, Worley, Michael J., May, Taymaa
Publicado 2021

TP53 Status is Associated with Thrombospondin1 Expression In vitro

por Alvarez Secord, Angeles, Bernardini, Marcus Q., Broadwater, Gloria, Grace, Lisa A., Huang, Zhiqing, Baba, Tsukasa, Kondoh, Eiji, Sfakianos, Gregory, Havrilesky, Laura J., Murphy, Susan K.
Publicado 2013

Expression signatures of TP53 mutations in serous ovarian cancers

por Bernardini, Marcus Q, Baba, Tsukasa, Lee, Paula S, Barnett, Jason C, Sfakianos, Gregory P, Secord, Angeles Alvarez, Murphy, Susan K, Iversen, Edwin, Marks, Jeffrey R, Berchuck, Andrew
Publicado 2010

Barriers to care for women with low-grade endometrial cancer and morbid obesity: a qualitative study

por Cusimano, Maria C, Simpson, Andrea N, Han, Angela, Hayeems, Robin, Bernardini, Marcus Q, Robertson, Deborah, Kives, Sari L, Satkunaratnam, Abheha, Baxter, Nancy N, Ferguson, Sarah E
Publicado 2019

High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation

por MacGregor, Heather L., Sayad, Azin, Elia, Andrew, Wang, Ben X., Katz, Sarah Rachel, Shaw, Patricia A., Clarke, Blaise A., Crome, Sarah Q., Robert-Tissot, Celine, Bernardini, Marcus Q., Nguyen, Linh T., Ohashi, Pamela S.
Publicado 2019

Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines

por Davidson, Brittany Anne, Rubatt, Jennifer M., Corcoran, David L., Teoh, Deanna K., Bernardini, Marcus Q., Grace, Lisa A., Soper, William John, Berchuck, Andrew, Siamakpour-Reihani, Sharareh, Chen, Wei, Owzar, Kouros, Murphy, Susan K., Secord, Angeles Alvarez
Publicado 2014